Halozyme - M&A Summary and Business Overview

Life ScienceCompany

Halozyme M&A Summary

Halozyme has acquired 1 company, including 1 in the last 5 years.

Halozyme’s largest acquisition to date was in 2022, when it acquired Antares Pharma for $960M. Halozyme has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Halozyme Business Overview

Where is Halozyme headquartered?

Halozyme is headquartered in San Diego, California.

What is Halozyme’s revenue?

Halozyme disclosed revenue of 829M USD for 2023 and 660M USD for 2022.

How many employees does Halozyme have?

Halozyme has 373 employees.

What sector is Halozyme in?

Halozyme is a life science company.

When was Halozyme founded?

Halozyme was founded in 1998.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 3

Halozyme

Halozyme Therapeutics, Inc.

12390 El Camino Real,
San Diego, California 92130
United States,
(858) 794-8889
www.halozyme.com

Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. The company advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients' lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE technology, which can reduce hours-long treatments to a matter of minutes, Halozyme's commercially-validated solution has touched more than 600,000 patient lives in post-marketing use via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs intended to deliver innovative therapies, with the potential to improve the lives of patients around the globe. Its proprietary enzyme rHuPH20 forms the basis of the ENHANZE technology and is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs to patients. Halozyme was formed in 1998 and is headquartered in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - 1 - - 1
vol $960M $960M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Antares Pharma, Inc. 2022-04-13 960M USD Add-on Acquisition
Ewing, New Jersey · www.antarespharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 960M (100%) - -
Total 1 $960M - -

By Geo

State/Country Buy Value Sell Value
United States 1 960M - -
  New Jersey 1 960M - -
Total 1 $960M - -

Top M&A Advisors

Financial Deals
BofA Securities
 1
Wells Fargo Securities
 1
Legal Deals
Weil Gotshal & Manges
 1

Deal Values

buy # Total
$100M to $1B 1 $960M
TOTAL $960M
Largest Antares Pharma, Inc.
$960M (2022-04-13)

Company Summary

SECTOR

Life Science

Revenue

829   26% 2023
660   49% 2022
443   66% 2021
268   37% 2020
196   29% 2019
152   2018
(millions of USD) Show More Show Less

Employees

373

Established

1998

Public

NASDAQ: HALO

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Halozyme

California Companies , Life Science Companies , United States Companies , California Life Science Companies , California Life Science with Acquisitions , California Life Science with Divestitures

Related Lists for California Companies

Largest California Companies , Acquisitive California Companies , Recently Acquired California Companies , Recently Sold California Companies , Private California Companies , Public California Companies , Acquired California Companies , PE Backed California Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal